Do you need a baseline mammogram?

Article

I recently went to the doctor for a past due exam – all clear, but the doctor reminded me that I would need a baseline mammogram at age 35."Umm ... 35? I thought it was 40 or 50? Why do I need a mammogram so early?""That's just what we do here," she replied.To my doctor's credit, I didn't question further about why a baseline mammogram is the norm in her practice, or what benefit it would give me. But I did want to do more research before I made a decision. Let's be perfectly clear. This is a baseline mammogram we're talking about. A baseline mammogram is taken first to compare to future mammograms when a woman decides to begin routine screening at 40 or 50. There's no evidence that this comparison between a baseline mammogram and the first routine screening holds any benefit. In addition, the baseline mammogram isn't looking for anything at this point. I have no family history of breast cancer. I don't have a suspicious lump or any other symptoms. I don't have dense breasts. I checked with my insurance company and they cover mammograms, regardless of age or reason. However, I can't find a professional group that recommends a baseline mammogram. The American College of Obstetricians and Gynecologists don't recommend them unless there is a family history. The American Cancer Society recommended baseline mammograms several decades ago, but removed it back in the early 1990s. So, why do some gynecologists still recommend them? I talked with Dr. Len at the ACS and he gave me some important background. He said the ACS recommended baseline mammograms from 1980 to 1991 because of the belief that they could help detect cancers in the future – comparing the mammography images from baseline and those taken later. (Here's a chronological depiction of the various guidelines from the ACS over the years.)Unfortunately, he says, baselines mammograms didn't help find cancers. Many times those baseline images weren't even available to compare with later images, and ultimately they just didn't prove to be very valuable. Women depend on their doctors to understand these guidelines and they should be comfortable being able to discuss the pros and cons with their patients, Dr. Len says. And an answer of "That's just what we do here," isn't helpful. This isn't to say I don't think young women should be screened for breast cancer. I know several young women who had symptoms, a family history or just a nagging concern that something was wrong but had to jump through hoops to get a mammogram or other screening test to finally diagnose breast cancer.When I asked on my Facebook page what other women thought of baseline mammograms, it generated a great discussion. Lisa, who was diagnosed with breast cancer at a young age only 18 months after a clean baseline mammogram, had some great advice: Any doctor should be able to give an answer to the question, "Why are you ordering this test, and why now?" If not, I'd press for better explanation for the timing. When told "that's just what we do," I'd definitely press that. "Why do you do what you do if research on screening's effectiveness contradicts your practice?"For now, I'm going to hold off. I have a few more years before I decide whether to start routine screenings at 40 or 50--and I have a feeling that will be a much harder decision. What do you think? Did you get a baseline mammogram?

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content